Condition
Liraglutide
Total Trials
4
Recruiting
0
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 4 (2)
Trial Status
Active Not Recruiting2
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07590219Phase 4Active Not Recruiting
Use of Liraglutide in Children Aged 6 to 12 Years With Severe Obesity
NCT04866667Completed
Observational Study of ASCVD Risks of Type 2 Diabetes in East China
NCT05221229Active Not Recruiting
Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )
NCT04781998Phase 4Completed
Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?
Showing all 4 trials